Targeting Pim kinases in hematological cancers: molecular and clinical review

M Bellon, C Nicot - Molecular Cancer, 2023 - Springer
Decades of research has recognized a solid role for Pim kinases in lymphoproliferative
disorders. Often up-regulated following JAK/STAT and tyrosine kinase receptor signaling …

[HTML][HTML] PIM kinase as an executional target in cancer

X Zhang, M Song, JK Kundu, MH Lee… - Journal of Cancer …, 2018 - ncbi.nlm.nih.gov
PIM (proviral integration site for moloney murine leukemia virus) kinase plays a key role as
an oncogene in various cancers including myeloma, leukemia, prostate and breast cancers …

Pim-1 kinase as cancer drug target: An update

Y Tursynbay, J Zhang, Z Li, T Tokay… - Biomedical …, 2016 - spandidos-publications.com
Proviral integration site for Moloney murine leukemia virus-1 (Pim-1) is a serine/threonine
kinase that regulates multiple cellular functions such as cell cycle, cell survival, drug …

Comprehensive insights that targeting PIM for cancer therapy: prospects and obstacles

L Chen, W Mao, C Ren, J Li… - Journal of Medicinal …, 2024 - ACS Publications
Proviral integration sitea for Moloney-murine leukemia virus (PIM) kinases are a family of
highly conserved serine/tyrosine kinases consisting of three members, PIM-1, PIM-2, and …

[HTML][HTML] The natural compound myricetin effectively represses the malignant progression of prostate cancer by inhibiting PIM1 and disrupting the PIM1/CXCR4 …

C Ye, C Zhang, H Huang, B Yang, G Xiao… - Cellular Physiology and …, 2018 - karger.com
Background/Aims: Natural compounds are a promising resource for anti-tumor drugs.
Myricetin, an abundant flavonoid found in the bark and leaves of bayberry, shows multiple …

Hispidulin: A promising flavonoid with diverse anti-cancer properties

K Liu, F Zhao, J Yan, Z Xia, D Jiang, P Ma - Life Sciences, 2020 - Elsevier
In recent years, natural products have increasingly attracted more attention because of their
potential anticancer activity and low intrinsic toxicity. Hispidulin is a natural flavonoid with a …

A serine/threonine protein PIM kinase as a biomarker of cancer and a target for anti-tumor therapy

NK Panchal, EP Sabina - Life sciences, 2020 - Elsevier
The PIM Kinases belong to the family of a proto-oncogene that essentially phosphorylates
the serine/threonine residues of the target proteins. They are primarily categorized into three …

Therapeutic targeting of PIM KINASE signaling in cancer therapy: Structural and clinical prospects

A Rathi, D Kumar, GM Hasan, MM Haque… - Biochimica et Biophysica …, 2021 - Elsevier
Background PIM kinases are well-studied drug targets for cancer, belonging to
Serine/Threonine kinases family. They are the downstream target of various signaling …

Retracted: Hispidulin suppresses cell growth and metastasis by targeting PIM1 through JAK2/STAT3 signaling in colorectal cancer

K Liu, H Gao, Q Wang, L Wang, B Zhang… - Cancer …, 2018 - Wiley Online Library
Colorectal cancer (CRC) accounts for over 600 000 deaths annually worldwide. The current
study aims to evaluate the value of proto‐oncogene PIM 1 as a therapeutic target in CRC …

Targeting PIM kinases in cancer therapy: An update on pharmacological small-molecule inhibitors

S Chen, Y Yang, Y Yuan, B Liu - European Journal of Medicinal Chemistry, 2023 - Elsevier
PIM kinases, a serine/threonine kinase family with three isoforms, has been well-known to
participate in multiple physiological processes by phosphorylating various downstream …